Abstract
Chondrosarcomas represent the second most common group of primary bone sarcomas. Their pathologic subcategorization is based on morphology and biological behavior and has been recently revised to better harmonize risk of metastasis with diagnostic terminology. Many of the different entities are associated with specific genetic aberrations, and their identification can be essential to accurate diagnosis. Patient management depends on the correct integration of key pathological, molecular, and imaging data.